Execution Improves but Dilution Stings; Phase 2 Financing Key Hinge

What happened

Digi Power X has shown operational progress with NeoCloudz and ARMS launches and progress at Columbiana, reducing execution risk. However, this progress came at a cost: significant shareholder dilution, with shares outstanding rising 41% in recent months to fund AI infrastructure. The Tier III AI segment remains pre-revenue as of Q1'26, and $14.6M in prepaid GPUs have not yet been received, making near-term revenue conversion uncertain. The Cerebras Phase 2 expansion is explicitly conditioned on securing adequate financing, which remains unresolved. While the narrative has shifted from pivot to measurable milestones, the stock price (~$6.70) bakes in delivery without fully discounting dilution and financing risk.

Implication

The improving operational milestones suggest DGXX is closer to commercialization, but heavy dilution and uncertain Phase 2 funding cap upside until proof of revenue and non-dilutive capital is evident. We recommend waiting for Q3'26 filing to confirm AI revenue and financing clarity before allocating.

Thesis delta

The company is executing on operational milestones, increasing the probability of eventual revenue, but the accelerating dilution and lack of financing for Phase 2 keep the risk-reward unfavorable. The shift is from 'pure speculation' to 'improving execution but still needing proof of revenue and funding', warranting a WAIT stance until tangible results emerge.